Big Pharma
Pfizer agrees with Metsera – wins bidding war with Novo Nordisk
Pfizer has entered into an agreement to acquire the American biotechnology company Metsera in a deal that could be worth...
The pharmaceutical sector is riding a USD 61,6 billion R&D wave
The pharmaceutical industry accelerates with 104 R&D deals in Q3...
Sanofi Ventures doubles down on early-stage biotech with $625M boost
As venture capital for early-stage biotech companies becomes increasingly limited...
Pfizer acquires Metsera for up to $7,3 billion
Pfizer makes comeback in obesity fight by acquiring...
Novo and Lilly in battle over blood sugar, weight and heart health
Over the past two days, Eli Lilly and...
Monte Rosa Therapeutics and Novartis expand collaboration
Monte Rosa Therapeutics surges on Nasdaq after...
Fierce battle for first place in the obesity race
In just a few years, obesity treatments have gone from...
The giants flee the UK – AstraZeneca and Eli Lilly come second
A bleak week for the UK life sciences sector...
M&A fever with over 280 deals in six months
The biopharma sector has had an explosive start to 2025....
Novo Nordisk restructures and lowers forecast
Novo Nordisk is implementing a comprehensive restructuring to...
Eli Lilly launches AI platform for biotech startups
On Tuesday, Eli Lilly launched its TuneLab –...
BioNTech's HER2 ADC outperforms Roche's Kadcyla in Phase III study
BioNTech, in collaboration with Duality Biologics, has achieved...